Melanoma’s speed varies dramatically depending on the subtype, but some forms can grow deep enough to spread in just a few months. Nodular melanoma, the fastest-growing type, shows a median duration of noticeable change of only 5 months before treatment, compared to 9 months for superficial spreading melanoma. Understanding what drives this variation helps you recognize danger signs early and grasp what a diagnosis means in practical terms.
Two Growth Phases That Determine Speed
Melanoma doesn’t simply expand outward at a steady rate. It progresses through two distinct phases, and the transition between them is what separates a treatable cancer from a dangerous one.
In the radial growth phase, melanoma cells spread horizontally across the skin’s surface. The lesion appears as an irregular, flat patch. Some cells may dip into the deeper skin layer (the dermis), but they don’t form a mass. During this phase, melanoma is highly curable because it hasn’t developed the ability to invade blood vessels or lymph channels.
In the vertical growth phase, the tumor shifts direction and begins growing downward, forming a true three-dimensional mass. This is the phase where melanoma gains the capacity to metastasize. Tumor depth, measured in millimeters from the skin surface, is the single most important factor in determining prognosis. Once a melanoma reaches 1 mm deep, the risk of spread increases meaningfully. At greater than 4 mm, the cancer is classified at the highest primary tumor stage.
How Speed Differs by Melanoma Subtype
The four major subtypes of cutaneous melanoma behave very differently, and knowing which type you’re dealing with changes the timeline considerably.
Superficial spreading melanoma is the most common subtype. It typically spends months to years in the radial growth phase, spreading across the skin surface before growing deeper. Patients usually notice changes over a median of about 9 months before seeking treatment, which often provides a window for early detection.
Nodular melanoma is the most dangerous common subtype precisely because it skips much of the radial phase. It enters the vertical growth phase early, pushing deep into the skin quickly. Patients report a median of only 5 months of noticeable change before treatment. This isn’t because people wait longer to get it checked. Research suggests nodular melanoma has a fundamentally more aggressive biology, growing thicker in a shorter time. It accounts for a disproportionate share of melanoma deaths relative to its frequency.
Lentigo maligna melanoma tends to develop on chronically sun-damaged skin, often on the face in older adults. It can spend years, sometimes over a decade, in the radial phase before becoming invasive.
Acral lentiginous melanoma appears on palms, soles, and under nails. It is often diagnosed late not because it grows faster, but because these locations are easily overlooked.
Measured Growth Rates in Millimeters
Researchers have measured how quickly different melanomas gain depth, and the differences are striking. A study of 196 tumors found that growth rates ranged from 0.12 mm per month to 0.61 mm per month depending on the tumor’s genetic profile. At the slower end, a melanoma might take 8 months to grow 1 mm deep. At the faster end, it could reach that same depth in under 2 months.
These numbers matter because depth directly determines staging. Melanomas 1 mm or thinner are classified as T1, with 5-year survival around 97 to 99%. Tumors between 1 and 2 mm are T2, those between 2 and 4 mm are T3, and anything thicker than 4 mm is T4. Whether the surface skin is broken (ulcerated) further affects the staging within each category. Each jump in thickness represents a meaningful drop in survival odds.
When Melanoma Starts Spreading to Other Organs
Melanoma can spread through two routes: the lymphatic system, which carries it to nearby lymph nodes and surrounding skin, and the bloodstream, which carries it to distant organs like the lungs, liver, brain, and bones.
One of the most unsettling findings in melanoma research is that tumor cells can break away from the primary site earlier than most people assume. Studies tracking the growth curves of metastatic melanoma back to their point of origin have found that cancer cells sometimes disseminate well before the patient notices any symptoms or seeks medical care. In some cases, spread occurred during the brief interval between clinical diagnosis and surgical removal. This doesn’t mean every melanoma has already spread by the time it’s found, but it underscores why early detection matters so much.
The body does have natural defenses that can slow this process. Immune cells, particularly a type of white blood cell called CD8+ T cells, can hold disseminated cancer cells in a dormant state, sometimes indefinitely. This phenomenon, called cancer dormancy, helps explain why some melanomas recur years or even decades after the original tumor was removed. The cancer cells were present but kept in check by the immune system until something shifted the balance.
What Makes Some Melanomas Faster
Several measurable factors predict how quickly a specific melanoma will progress.
Mitotic rate counts how many cells in a tissue sample are actively dividing. It is the strongest predictor of survival after tumor thickness. Ten-year survival drops from 93% for tumors with no dividing cells per square millimeter to 48% for those with 20 or more. A high mitotic rate signals a tumor that is growing rapidly and more likely to metastasize early.
Genetic mutations also influence speed, though not always in the direction you might expect. BRAF mutations are present in roughly 40% of melanomas. Tumors carrying the most common BRAF variant (V600E) actually tend to grow more slowly, at about 0.12 mm per month. A less common BRAF variant (V600K) drives growth nearly five times faster, at 0.61 mm per month. Tumors with NRAS mutations fall in between at 0.36 mm per month. Counterintuitively, having a BRAF mutation is still associated with poorer long-term survival in early-stage disease despite slower initial growth.
Ulceration of the tumor surface, visible as a broken or eroded area over the melanoma, independently worsens prognosis at every thickness level. A 2 mm melanoma with ulceration is staged more aggressively than the same thickness without it.
Tumor location plays a role too. Scalp melanomas tend to invade blood vessels more readily, behaving similarly to cancers known for blood-borne spread like kidney cancer. This may explain why head and neck melanomas carry a worse prognosis than those on the trunk or limbs.
Melanomas That Are Easy to Miss
Amelanotic melanoma lacks the dark pigment most people associate with skin cancer. It can appear pink, red, or skin-colored, and is frequently mistaken for a pimple, bug bite, or benign growth. This subtype carries a less favorable prognosis, largely because it’s diagnosed at a more advanced stage. The rapid progression, later detection, and higher rates of lymph node involvement and distant spread account for its increased severity.
The standard ABCDE criteria (Asymmetry, Border irregularity, Color variation, Diameter, Evolution) work well for flat, pigmented melanomas but can miss nodular and amelanotic types entirely. For these, dermatologists use the EFG criteria: Elevated, Firm, and Growing. A nodular melanoma tends to grow with changes visible over days to weeks, while benign skin lesions remain stable or change slowly over years. Any new raised, firm lump on the skin that is visibly growing deserves prompt evaluation, regardless of its color.
Survival by Stage at Diagnosis
The gap in outcomes between early and late detection is enormous. For a thin melanoma (0.8 to 1.0 mm) without lymph node involvement, 5-year melanoma-specific survival is 99% for those staged by pathology. Even with conservative clinical staging, it remains 97%.
Once melanoma reaches the lymph nodes (Stage III), outcomes become far more variable. Stage IIIA, where only a microscopic amount of cancer is found in a nearby lymph node, still carries a 93% five-year survival rate. But Stage IIID, with thicker primary tumors, ulceration, and greater lymph node involvement, drops to 32%. This wide range within a single stage reflects just how much the specific characteristics of a melanoma matter beyond a simple “it has spread” label.
These numbers reinforce a straightforward reality: the speed at which melanoma spreads is less important than the depth and stage at which it’s caught. A slow-growing melanoma ignored for years can be more dangerous than an aggressive one detected early. Monthly self-skin checks, attention to changing or new lesions, and awareness that not all melanomas are dark and flat remain the most effective tools for catching this cancer while the numbers are still in your favor.